ID

12100

Descrizione

Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT02141477

collegamento

https://clinicaltrials.gov/show/NCT02141477

Keywords

versioni (1)
  1. 22/09/15 22/09/15 - Julian Varghese
Caricato su

22 settembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Leukemia NCT02141477

Inglese

Eligibility Leukemia NCT02141477

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT02141477
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. previously untreated aml (>/= 20% blasts) or aml m6. patients with high-risk (intermediate-2 or high by ipss or >/= 10% blasts) mds will also be eligible. prior therapy with hydroxyurea, biological or targeted therapy (e.g. flt3 inhibitors, other kinase inhibitors, azacitidine), or hematopoietic growth factors is allowed. no prior chemotherapy is allowed except for a single or a two day dose of cytarabine (up to 3 g/m2) for emergency use is also allowed as prior therapy.
Descrizione

Acute Erythroblastic Leukemia | Leukemia, Myelocytic, Acute; Did not receive therapy or drug for | Myelodysplastic-Myeloproliferative Diseases | Prior Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023440
UMLS CUI [2,1]
C0023467
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C1301355
UMLS CUI [4]
C1514457
2. age >/= 70 years.
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
3. ecog performance status </= 2.
Descrizione

ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
4. adequate hepatic (serum total bilirubin </= 1.5 x uln, sgpt and/or sgot </= 2.5 x uln) and renal function (creatinine </= 2.0 mg/dl).
Descrizione

Serum total bilirubin measurement | SGOT - Glutamate oxaloacetate transaminase | SGPT - Glutamate pyruvate transaminase | SGPT - Glutamate pyruvate transaminase | Creatinine measurement, serum (procedure)

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0242192
UMLS CUI [3]
C0376147
UMLS CUI [4]
C0376147
UMLS CUI [5]
C0201976
5. patients must be willing and able to review, understand, and provide written consent before starting therapy.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
6. men of childbearing potential who agree to use contraception prior to study entry and for the duration of participation.
Descrizione

Childbearing Potential | Contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. nyha class iii or iv heart disease, active ischemia or any other uncontrolled cardiac condition such as angina pectoris, clinically significant cardiac arrhythmia and requiring therapy, uncontrolled hypertension (blood pressure >/= 160 systolic and >/= 110 diastolic not responsive to antihypertensive medication), uncontrolled diabetes mellitus, or congestive heart failure.
Descrizione

New York Heart Association Classification | Cardiac Arrhythmia | Uncontrolled hypertension | Diabetic - poor control | Congestive heart failure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1275491
UMLS CUI [2]
C0003811
UMLS CUI [3]
C1868885
UMLS CUI [4]
C0421258
UMLS CUI [5]
C0018802
2. myocardial infarction in the previous 12 weeks (from the start of treatment).
Descrizione

Myocardial Infarction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027051
3. active and uncontrolled disease/infection as judged by the treating physician.
Descrizione

Disease condition determination, uncontrolled | Communicable Diseases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0184774
UMLS CUI [2]
C0009450
4. acute promyelocytic leukemia (apl).
Descrizione

acute promyelocytic leukemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023487
Ritorna all'inizio della pagina

Similar models

Eligibility Leukemia NCT02141477

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT02141477
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Acute Erythroblastic Leukemia | Leukemia, Myelocytic, Acute; Did not receive therapy or drug for | Myelodysplastic-Myeloproliferative Diseases | Prior Chemotherapy
Item
1. previously untreated aml (>/= 20% blasts) or aml m6. patients with high-risk (intermediate-2 or high by ipss or >/= 10% blasts) mds will also be eligible. prior therapy with hydroxyurea, biological or targeted therapy (e.g. flt3 inhibitors, other kinase inhibitors, azacitidine), or hematopoietic growth factors is allowed. no prior chemotherapy is allowed except for a single or a two day dose of cytarabine (up to 3 g/m2) for emergency use is also allowed as prior therapy.
boolean
C0023440 (UMLS CUI [1])
C0023467 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C1301355 (UMLS CUI [3])
C1514457 (UMLS CUI [4])
age
Item
2. age >/= 70 years.
boolean
C0001779 (UMLS CUI [1])
ecog performance status
Item
3. ecog performance status </= 2.
boolean
C1520224 (UMLS CUI [1])
Serum total bilirubin measurement | SGOT - Glutamate oxaloacetate transaminase | SGPT - Glutamate pyruvate transaminase | SGPT - Glutamate pyruvate transaminase | Creatinine measurement, serum (procedure)
Item
4. adequate hepatic (serum total bilirubin </= 1.5 x uln, sgpt and/or sgot </= 2.5 x uln) and renal function (creatinine </= 2.0 mg/dl).
boolean
C1278039 (UMLS CUI [1])
C0242192 (UMLS CUI [2])
C0376147 (UMLS CUI [3])
C0376147 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
Informed Consent
Item
5. patients must be willing and able to review, understand, and provide written consent before starting therapy.
boolean
C0021430 (UMLS CUI [1])
Childbearing Potential | Contraceptive methods
Item
6. men of childbearing potential who agree to use contraception prior to study entry and for the duration of participation.
boolean
C3831118 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
New York Heart Association Classification | Cardiac Arrhythmia | Uncontrolled hypertension | Diabetic - poor control | Congestive heart failure
Item
1. nyha class iii or iv heart disease, active ischemia or any other uncontrolled cardiac condition such as angina pectoris, clinically significant cardiac arrhythmia and requiring therapy, uncontrolled hypertension (blood pressure >/= 160 systolic and >/= 110 diastolic not responsive to antihypertensive medication), uncontrolled diabetes mellitus, or congestive heart failure.
boolean
C1275491 (UMLS CUI [1])
C0003811 (UMLS CUI [2])
C1868885 (UMLS CUI [3])
C0421258 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
Myocardial Infarction
Item
2. myocardial infarction in the previous 12 weeks (from the start of treatment).
boolean
C0027051 (UMLS CUI [1])
Disease condition determination, uncontrolled | Communicable Diseases
Item
3. active and uncontrolled disease/infection as judged by the treating physician.
boolean
C0184774 (UMLS CUI [1])
C0009450 (UMLS CUI [2])
acute promyelocytic leukemia
Item
4. acute promyelocytic leukemia (apl).
boolean
C0023487 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial